SCHEMBL5048683

SCHEMBL5048683

COCCn1c(-c2csc(-c3cnccn3)n2)cc(C(=O)O)c1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KLKB1 P03952 1/20 0.44
KLK1 P06870 1/20 0.44
HDAC1 Q13547 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
HSD17B10 Q99714 2/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
HPGD P15428 1/20 0.40
CDC7 O00311 1/20 0.39
DBF4 Q9UBU7 1/20 0.39
HTT P42858 2/20 0.36
RECQL P46063 1/20 0.36
CPT2 P23786 1/20 0.35
CPT1A P50416 1/20 0.35
CPT1B Q92523 1/20 0.35
EIF4E P06730 1/20 0.35
CCNC P24863 1/20 0.35
CDK8 P49336 1/20 0.35
HASPIN Q8TF76 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5044289 0.94 KLKB1 (0.42) KLKB1KLK1HDAC1HDAC8HDAC6
SCHEMBL5043558 0.87 KLKB1 (0.47) KLKB1KLK1HDAC1HDAC8HDAC6
SCHEMBL5043461 0.87 KLKB1 (0.42) KLKB1KLK1HDAC1HDAC8HDAC6
SCHEMBL5043692 0.86 KLKB1 (0.46) KLKB1KLK1HDAC1HDAC8HDAC6
SCHEMBL5044584 0.84 KLKB1 (0.43) KLKB1KLK1HDAC1HDAC8HDAC6
SCHEMBL5043868 0.83 KLKB1 (0.46) KLKB1KLK1HDAC1HDAC8HDAC6
SCHEMBL5044577 0.83 KLKB1 (0.46) KLKB1KLK1HDAC1HDAC8HDAC6
SCHEMBL5043694 0.82 EIF4E (0.41) KDM4EALDH1A1CPT2CPT1ACPT1B
SCHEMBL6069332 0.80 SREBF2 (0.49) ALDH1A1CDC7DBF4EIF4E
SCHEMBL5039577 0.80 KLKB1 (0.42) KLKB1KLK1HDAC1HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1583762-B1 PYRROLYL-THIAZOLES AND THEIR USE AS CB 1 RECEPTOR INVERSE AGONISTS HOFFMANN LA ROCHE (CH) 2008-07-09 EP disclosed
US-7135488-B2 Pyrrolyl-thiazole derivatives HOFFMANN-LA ROCHE INC. (US) 2006-11-14 US disclosed
US-20040147572-A1 Novel pyrrolyl-thiazole derivatives HOFFMAN-LA ROCHE INC. 2004-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040147572-A1 Novel pyrrolyl-thiazole derivatives CNR1, CNR2, NPY1R KLKB1 3949/4885KLK1 3547/4885HDAC1 688/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.